Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alan Pillersdorf

Plastic Surgery West Palm Beach, FL Medical Doctor

NPI 1750366126 CMS profile 170600

4700 N Congress Ave Suite 103, West Palm Beach, FL 33407

Open in the dashboard

General payments

$5,241

116 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alan Pillersdorf of West Palm Beach, FL is reported in the CMS Open Payments database as having received $5,241 across 116 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $386 9
2024 General $823 16
2023 General $468 16
2022 General $502 13
2021 General $875 21
2020 General $639 16
2019 General $1,549 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alan Pillersdorf
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Alan Pillersdorf were reported at $386. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Alan Pillersdorf Plastic Surgery median Middle half National median
2019 $1,549 $371 $122–$1,483 $163
2020 $639 $158 $52–$438 $114
2021 $875 $249 $87–$752 $132
2022 $502 $274 $102–$793 $149
2023 $468 $299 $113–$891 $160
2024 $823 $361 $124–$1,062 $164
2025 $386 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $1,886 55 payments
  2. Medical Device Business Services, Inc. $967 6 payments
  3. Sientra, Inc. $609 11 payments
  4. Musculoskeletal Transplant Foundation Inc. $414 5 payments
  5. AbbVie, Inc. $257 9 payments
  6. Galderma Laboratories, L.P. $180 3 payments
  7. TELA Bio, Inc. $173 3 payments
  8. Solta Medical, a division of Bausch Health US, LLC $141 2 payments
  9. Davol Inc. $111 1 payment
  10. Allergan Inc. $106 6 payments
  11. Other $398 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,318 113 payments
  2. Travel and Lodging $773 2 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $150 1 payment
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $1,416 37 payments
  2. ARTOURA Breast Tissue Expander Plastic Surgery $886 30 payments
  3. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $609 11 payments
  4. MemoryGel Breast Implants $391 12 payments
  5. ARTOURA Breast Tissue Expander Plastic Surgery $322 12 payments
  6. MemoryShape Breast Implants $201 2 payments
  7. SILTEX Breast Implants $149 4 payments
  8. OviTex 2S $125 1 payment
  9. PHASIX $111 1 payment
  10. HEMOBLAST BELLOWS $77 2 payments
  11. Other $725 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

529

Median for Plastic and Reconstructive Surgery: 61

Drug cost

$2,426

Median for Plastic and Reconstructive Surgery: $369

Branded share of claims

17.4%

Median for Plastic and Reconstructive Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 319 $874
Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha Brand 33 $372
Mupirocin Generic 45 $327
Azithromycin Generic 42 $245
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 25 $194
Scopolamine Generic 15 $180
Acetaminophen-Codeine Acetaminophen With Codeine Brand 17 $104
Ciprofloxacin Hcl Generic 16 $87
Ondansetron Odt Ondansetron Brand 17 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$150,364

Medicare's payments for the services billed

Medicare patients

205

Average age 76

Services billed

582

114 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 54%
Ischemic heart disease 40%
Diabetes 30%
Chronic kidney disease 30%
Heart failure 23%
Atrial fibrillation 23%
Depression 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

116 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record